Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.
BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...
Gsync Pulsar is going to live or die by how well it handles refresh rates that are actually, well, variable. The motion ...
NEW YORK, NY, UNITED STATES, January 6, 2026 /EINPresswire.com/ — Panther Life Sciences announces expanded access to its high-precision Microarray Patch (MAP) platform for pharmaceutical and ...
Many projects on these pages do clever things with video. Whether it’s digital or analogue, it’s certain our community can ...
One of the most well-studied cellular responses is how they react during times of stress, such as when the temperature gets ...
Researchers say the innovation, known as SmartEM, will speed scanning sevenfold and open the field of connectomics to a ...
Brisbane-based Vaxxas has appointed David Peacock to lead the push to bring its vaccine patch technology to market.
New Scientist on MSN
Super-low density worlds reveal how common planetary systems form
Most planetary systems contain worlds larger than Earth but smaller than Neptune, and the low-density planets around one ...
The software firm has again been recognized as one of the 100 Best Large Places to Work in Chicago by Built In We are ...
This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback